Advertisement
CVS vs UNH
Which Stock Would AI Choose? CVS Health (CVS) vs. UnitedHealth Group (UNH) Stock Comparison
Key Takeaways
- CVS trades at a notably lower valuation with a higher dividend yield, while UNH commands a premium multiple backed by greater scale and profitability.
- Both companies are recovering from elevated medical-cost pressure, but UNH has shown more consistent recent momentum and analyst upgrades.
- CVS is executing a margin-recovery story at Aetna, offset by pharmacy benefit manager (PBM) and 340B program headwinds.
- UNH benefits from diversification through Optum and improved Medicare Advantage rate visibility.
- Risk profiles differ: CVS faces reimbursement and membership pressure, while UNH faces regulatory scrutiny and a higher valuation bar.
Introduction
CVS Health and UnitedHealth Group are two of the most closely watched names in U.S. healthcare, yet they represent very different investment profiles. This stock comparison is relevant for traders and investors evaluating relative performance and market positioning within the managed care and healthcare-services sector. Both companies are navigating a common environment of elevated medical utilization, changing pharmacy benefit economics, and evolving Medicare policy, but their scale, diversification, and recent trajectories have diverged. Investors seeking income and deep value may gravitate toward CVS, while those prioritizing stability and earnings consistency often look to UNH.
CVS Overview and Recent Performance
CVS Health is a vertically integrated healthcare company combining one of the largest U.S. pharmacy chains, the Aetna health insurer, and the CVS Caremark pharmacy benefit manager (PBM), which negotiates drug pricing for health plans and employers. In recent weeks, the stock has faced renewed selling pressure, including a multi-session losing streak, and has underperformed the broader market over the trailing month despite remaining positive year-to-date. The shares have pulled back notably from a 52-week high reached in the summer.
Fundamentally, CVS delivered a strong second-quarter report, with adjusted earnings per share (EPS) rising sharply year over year, revenue growth of roughly 7%, and raised full-year guidance. The Aetna segment's medical benefit ratio improved, supporting a margin-recovery narrative. However, sentiment has been tempered by management commentary flagging expected declines in Caremark membership and a continuing 340B program headwind (a federal drug-discount program) projected to pressure 2027 results. This mix of improving near-term profitability and lingering structural concerns has kept relative performance choppy.
UNH Overview and Recent Performance
UnitedHealth Group is the largest U.S. health insurer and a diversified healthcare platform, operating through UnitedHealthcare and the Optum businesses (Optum Health, Optum Insight, and Optum Rx). In recent market activity, UNH has been a relative outperformer, rising significantly year-to-date and recovering from a difficult prior year. The shares have pulled back modestly from a 52-week high but remain well above their 52-week low.
The company's recent performance has been driven by improving cost control, with its medical care ratio (MCR) — the share of premiums paid out in claims — declining as pricing discipline and benefit design take hold. UnitedHealth has raised its full-year adjusted EPS outlook for consecutive quarters and has pointed to progress in the Optum Health turnaround. Analysts have responded with a wave of price-target increases and several upgrades, citing Medicare Advantage rate visibility and a large artificial intelligence (AI) investment program management says is delivering returns. Regulatory scrutiny and a premium valuation remain the primary counterweights to an otherwise constructive narrative.
Trending AI Robots
For traders who prefer a systematic, data-driven approach to this kind of stock comparison, Tickeron's Trending AI Robots page offers a curated view of AI-powered trading tools. Tickeron hosts hundreds of AI trading bots that collectively trade thousands of different tickers, but only those best suited to current market conditions earn a place in this featured section. These bots span a wide range of trading styles, strategies, timeframes, performance statistics, and sets of tickers, allowing users to evaluate them by criteria such as volatility, signal frequency, and historical results. Browsing the curated list can help you identify which automated strategies are currently aligned with the behavior of names like CVS and UNH. Explore the Trending AI Robots to see which strategies are gaining traction right now.
Head-to-Head Comparison
The two companies differ most sharply in business mix and scale. CVS is a diversified pharmacy-and-insurance operator with meaningful exposure to retail pharmacy and PBM economics, while UnitedHealth pairs a dominant insurance franchise with the fast-growing, higher-margin Optum health-services platform. This gives UNH a more balanced earnings profile and a market capitalization several times larger than CVS.
On valuation, the contrast is stark. CVS trades at a low-teens forward price-to-earnings (P/E) multiple with a dividend yield around 3%, reflecting deep-value positioning. UNH trades at a higher forward multiple with a lower yield, reflecting its premium market positioning. On momentum, UNH has been the steadier performer, while CVS has shown greater volatility as investors weigh a promising earnings recovery against PBM and reimbursement risks. Both face policy and medical-cost uncertainty, but CVS carries more company-specific structural headwinds, whereas UNH's risks skew toward regulatory exposure and a richer valuation.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely lean toward UNH in the current environment. The stock has demonstrated more consistent trend behavior, stronger recent relative performance, and a steadier stream of positive estimate revisions and price-target increases. Its diversified Optum platform and improving medical cost ratio provide a clearer catalyst path. CVS offers compelling value and a higher yield, which could appeal under a mean-reversion scenario, but its relative positioning is currently more mixed given structural PBM and 340B headwinds. This assessment reflects probabilistic analysis of trend consistency and momentum rather than a definitive claim about future returns.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVS is a Buy and UNH is a StrongBuy.
CVS | UNH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 2 Undervalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 83 | 100 | |
SMR RATING 1..100 | 81 | 57 | |
PRICE GROWTH RATING 1..100 | 56 | 48 | |
P/E GROWTH RATING 1..100 | 31 | 10 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (2) in the Drugstore Chains industry is in the same range as UNH (4) in the Managed Health Care industry. This means that CVS’s stock grew similarly to UNH’s over the last 12 months.
CVS's Profit vs Risk Rating (83) in the Drugstore Chains industry is in the same range as UNH (100) in the Managed Health Care industry. This means that CVS’s stock grew similarly to UNH’s over the last 12 months.
UNH's SMR Rating (57) in the Managed Health Care industry is in the same range as CVS (81) in the Drugstore Chains industry. This means that UNH’s stock grew similarly to CVS’s over the last 12 months.
UNH's Price Growth Rating (48) in the Managed Health Care industry is in the same range as CVS (56) in the Drugstore Chains industry. This means that UNH’s stock grew similarly to CVS’s over the last 12 months.
UNH's P/E Growth Rating (10) in the Managed Health Care industry is in the same range as CVS (31) in the Drugstore Chains industry. This means that UNH’s stock grew similarly to CVS’s over the last 12 months.
| CVS | UNH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 67% | 2 days ago 73% |
| Stochastic ODDS (%) | 2 days ago 60% | 2 days ago 57% |
| Momentum ODDS (%) | 2 days ago 57% | 2 days ago 59% |
| MACD ODDS (%) | 2 days ago 56% | 2 days ago 66% |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 57% | 2 days ago 57% |
| Advances ODDS (%) | N/A | 5 days ago 56% |
| Declines ODDS (%) | 2 days ago 60% | 2 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 75% | 2 days ago 63% |
| Aroon ODDS (%) | 2 days ago 58% | 2 days ago 53% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVS’s FA Score shows that 2 FA rating(s) are green while UNH’s FA Score has 2 green FA rating(s).
- CVS’s FA Score: 2 green, 3 red.
- UNH’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVS’s TA Score shows that 3 TA indicator(s) are bullish while UNH’s TA Score has 4 bullish TA indicator(s).
- CVS’s TA Score: 3 bullish, 4 bearish.
- UNH’s TA Score: 4 bullish, 4 bearish.
Price Growth
CVS (@Managed Health Care) experienced а +0.18% price change this week, while UNH (@Managed Health Care) price change was -2.62% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was -0.93%. For the same industry, the average monthly price growth was -7.57%, and the average quarterly price growth was +57.20%.
Reported Earning Dates
CVS is expected to report earnings on Nov 04, 2026.
UNH is expected to report earnings on Oct 13, 2026.
Industries' Descriptions
@Managed Health Care (-0.93% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
Advertisement
CVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVS has been closely correlated with UNH. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if CVS jumps, then UNH could also see price increases.
UNH and
Correlation & Price change
A.I.dvisor indicates that over the last year, UNH has been closely correlated with ELV. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if UNH jumps, then ELV could also see price increases.